Psychotropic drug use among preschool children in the Medicaid program from 36 states

Lauren D Garfield1, Derek S Brown, Benjamin T Allaire

  • 1Lauren D. Garfield, Derek S. Brown, Raven E. Ross, Ginger E. Nicol, and Ramesh Raghavan are with Washington University, St Louis, MO. Benjamin T. Allaire is with RTI International, Research Triangle Park, NC.

Insights

Preschool children in Medicaid are receiving psychotropic medications, primarily for attention-deficit disorders. This study highlights the need for more research on the safety and efficacy of these drugs in young children.

Area of Science:

  • Pediatric pharmacology
  • Public health
  • Child psychiatry

Background:

  • Psychotropic medication use in preschool-aged children is a growing concern.
  • Limited evidence exists regarding the safety and efficacy of these medications in young children.
  • Understanding prescribing patterns is crucial for improving child health outcomes.

Purpose of the Study:

  • To determine the prevalence of psychotropic medication use among preschool children enrolled in Medicaid.
  • To identify the specific indications for which these medications are prescribed.
  • To analyze demographic and insurance-related factors associated with psychotropic medication prescription.

Main Methods:

  • Utilized Medicaid Analytic Extract data from 36 states (2000-2003).
  • Followed two cohorts of children (born 1999 and 2000) up to age 4.
  • Employed logistic regression to model the odds of receiving medications for ADHD, depression/anxiety, and psychotic/bipolar disorders.

Main Results:

  • 1.19% of preschool children received at least one psychotropic medication.
  • Attention-deficit disorder/attention-deficit hyperactivity disorder (ADHD) medications were most common (0.61%).
  • Boys, children of other/unknown race, and those with other insurance types showed higher odds of prescription; Black and Hispanic children had lower odds.

Conclusions:

  • Psychotropic medications are being prescribed to preschoolers despite insufficient evidence of safety or efficacy.
  • There is a need to implement medication use practice parameters in early childhood clinics.
  • Expanding psychosocial interventions for young children with behavioral issues is recommended.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Altered States of Awareness01:06

Altered States of Awareness

Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
1.1K